{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:49:27Z","timestamp":1791038967627,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1038\/3300","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:43:54Z","timestamp":1027673034000},"page":"1308-1312","source":"Crossref","is-referenced-by-count":88,"title":["Combined PET\/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Anna-Liisa","family":"Brownell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Elmaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence W.","family":"Deacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Spealman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm1198_1308_CR1","unstructured":"Gjaedde, A. & Wong, D.F. Modeling neuroreceptor binding of radioligands in vivo. Quant. Imaging 51\u2013 79 (1990)."},{"key":"BFnm1198_1308_CR2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/jcbfm.1991.156","volume":"11","author":"J Delforge","year":"1991","unstructured":"Delforge, J.  et al. Kinetic analysis of central (76)bromolisuride binding to dopamine D2-receptors studied by PET. J. Cereb. Blood Flow Metab.  11, 914\u2013925 ( 1991).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnm1198_1308_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-7091-6842-4_5","volume":"50","author":"KL Leenders","year":"1997","unstructured":"Leenders, K.L. Pathophysiology of movement disorders studied using PET. J. Neural Transm. Suppl. 50, 39\u201346 (1997).","journal-title":"J. Neural Transm. Suppl."},{"key":"BFnm1198_1308_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0730-725X(97)00079-9","volume":"15","author":"CJ Cruz","year":"1997","unstructured":"Cruz, C.J., Aminoff, M.J., Meyerhoff, D.J., Graham, S.H. & Weiner, M.W. Proton MR spectroscopic imaging of the striatum in Parkinson's disease. Magn. Reson. Imaging  15, 619\u2013624 (1997).","journal-title":"Magn. Reson. Imaging"},{"key":"BFnm1198_1308_CR5","first-page":"589","volume":"33","author":"BA Holshouser","year":"1995","unstructured":"Holshouser, B.A. et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.  Magn. Reson. Imaging 33, 589\u2013594 (1995).","journal-title":"Magn. Reson. Imaging"},{"key":"BFnm1198_1308_CR6","first-page":"S6","volume":"43","author":"DJ Brooks","year":"1993","unstructured":"Brooks, D.J. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 43, S6\u2013S16 (1993).","journal-title":"Neurology"},{"key":"BFnm1198_1308_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.410310315","volume":"31","author":"K Herholz","year":"1992","unstructured":"Herholz, K.  et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann. Neurol. 31, 319\u2013327 (1992).","journal-title":"Ann. Neurol."},{"key":"BFnm1198_1308_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1148\/radiology.177.3.2243962","volume":"177","author":"JR Alger","year":"1990","unstructured":"Alger, J.R., Frank, J.L., van Zijl, P.C., Moonen, C.T. & DiChiro, G. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology  177, 633\u2013641 ( 1990).","journal-title":"Radiology"},{"key":"BFnm1198_1308_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/jcbfm.1992.104","volume":"12","author":"JW Hugg","year":"1992","unstructured":"Hugg, J.W.  et al. Elevated lactate and alkalosis in chronic human brain infarction observed by 1H and 31P MR spectroscopic imaging. J. Cereb. Blood Flow Metab. 12, 734\u2013744 (1992).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnm1198_1308_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1212\/WNL.42.7.1349","volume":"42","author":"OA Petroff","year":"1992","unstructured":"Petroff, O.A.  et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 42, 1349\u20131354 (1992).","journal-title":"Neurology"},{"key":"BFnm1198_1308_CR11","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1073\/pnas.88.13.5829","volume":"88","author":"J Prichard","year":"1991","unstructured":"Prichard, J.  et al. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc. Natl. Acad. Sci. USA  88, 5829\u20135831 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1308_CR12","first-page":"15","volume":"6","author":"AH Schapira","year":"1997","unstructured":"Schapira, A.H. Pathogenesis of Parkinson's disease. Baillieres Clin. Neurol.  6, 15\u201336 (1997).","journal-title":"Baillieres Clin. Neurol."},{"key":"BFnm1198_1308_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.410340331","volume":"34","author":"JJ Frost","year":"1993","unstructured":"Frost, J.J.  et al. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.  Ann. Neurol. 34, 423\u2013431 (1993).","journal-title":"Ann. Neurol."},{"key":"BFnm1198_1308_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer, H. & Hornykiewicz, O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr.  38, 1236\u20131239 (1960).","journal-title":"Klin. Wochenschr."},{"key":"BFnm1198_1308_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3940(86)90242-9","volume":"68","author":"SB Dunnett","year":"1986","unstructured":"Dunnett, S.B., Whishaw, I.Q., Jones, G.H. & Isacson, O. Effects of dopamine-rich grafts on conditioned rotation in rats with unilateral 6-hydroxydopamine lesions. Neurosci. Lett. 68, 127\u2013135 (1986).","journal-title":"Neurosci. Lett."},{"key":"BFnm1198_1308_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt, U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons.  Eur. J. Pharmacol. 5, 107\u2013110 (1968).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnm1198_1308_CR17","first-page":"49","volume":"100","author":"JW Langston","year":"1984","unstructured":"Langston, J.W., Langston, E.B. & Irwin, I. MPTP-induced parkinsonism in human and non-human primates\u2014clinical and experimental aspects. Acta Neurol. Scand. Suppl.  100, 49\u201354 (1984).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"BFnm1198_1308_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/317246a0","volume":"317","author":"DD Calne","year":"1985","unstructured":"Calne, D.D.  et al. Positron emission tomography after MPTP. Nature  317, 244\u2013248 ( 1985).","journal-title":"Nature"},{"key":"BFnm1198_1308_CR19","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns, R.S.  et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546\u2013 4550 (1983).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1308_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/0024-3205(86)90336-X","volume":"39","author":"P Hantraye","year":"1986","unstructured":"Hantraye, P.  et al. In vivo visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primates. Life Sci. 39, 1375\u2013 1382 (1986).","journal-title":"Life Sci."},{"key":"BFnm1198_1308_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0006-8993(88)90446-5","volume":"474","author":"H Imai","year":"1988","unstructured":"Imai, H., Nakamura, T., Endo, K. & Narabayashi, H. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP): behavior and histology. Brain Res. 474, 327\u2013338 (1988).","journal-title":"Brain Res."},{"key":"BFnm1198_1308_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00001756-199203000-00013","volume":"3","author":"P Hantraye","year":"1992","unstructured":"Hantraye, P.  et al. Dopamine fiber detection by [11 C]-CFT and PET in a primate model of parkinsonism. Neuroreport 3, 265 \u2013268 (1992).","journal-title":"Neuroreport"},{"key":"BFnm1198_1308_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/exnr.1994.1069","volume":"126","author":"U Wullner","year":"1994","unstructured":"Wullner, U.  et al. Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT. Exp. Neurol. 126, 305\u2013309 ( 1994).","journal-title":"Exp. Neurol."},{"key":"BFnm1198_1308_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00019052-199608000-00011","volume":"9","author":"JA Temlett","year":"1996","unstructured":"Temlett, J.A. Parkinson's disease: biology and aetiology. Curr. Opin. Neurol.  9, 303\u2013307 ( 1996).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnm1198_1308_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/syn.890190107","volume":"19","author":"PA Frohna","year":"1995","unstructured":"Frohna, P.A., Rothblat, D.S., Joyce, J.N. & Schneider, J.S. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse  19, 46\u201355 (1995).","journal-title":"Synapse"},{"key":"BFnm1198_1308_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mrm.1910370106","volume":"37","author":"I Strauss","year":"1997","unstructured":"Strauss, I., Williamson, J.M., Bertram, E.H., Lothman, E.W. & Fernandez, E.J. Histological and 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum. Magn. Reson. Med. 37, 24\u201333 (1997).","journal-title":"Magn. Reson. Med."},{"key":"BFnm1198_1308_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/mrm.1910370608","volume":"37","author":"T Higuchi","year":"1997","unstructured":"Higuchi, T.  et al. Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain. Magn. Reson. Med.  37, 851\u2013857 (1997).","journal-title":"Magn. Reson. Med."},{"key":"BFnm1198_1308_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00004647-199605000-00011","volume":"16","author":"BG Jenkins","year":"1996","unstructured":"Jenkins, B.G., et al. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J. Cereb. Blood Flow Metab. 16, 450\u2013 461 (1996).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnm1198_1308_CR29","first-page":"1093","volume":"69","author":"AR Guimareaeas","year":"1995","unstructured":"Guimareaeas, A.R. et al. Quantitative nuclear magnetic resonance spectroscopic imaging of neuronal loss in excitotoxic rat brain model. Neuroscience  69, 1093\u20131101 ( 1995).","journal-title":"Neuroscience"},{"key":"BFnm1198_1308_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.410360115","volume":"36","author":"DL Arnold","year":"1994","unstructured":"Arnold, D.L.  et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann. Neurol.  36, 76\u201382 (1994).","journal-title":"Ann. Neurol."},{"key":"BFnm1198_1308_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/brain\/117.1.49","volume":"11","author":"CA Davies","year":"1994","unstructured":"Davies, C.A.  et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 11, 49\u2013 58 (1994).","journal-title":"Brain"},{"key":"BFnm1198_1308_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0149-7634(89)80048-X","volume":"1","author":"DL Birken","year":"1989","unstructured":"Birken, D.L. & Olendorf, W.H. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of the brain. Neurosci. Biobehav. 1, 23\u2013 31 (1989).","journal-title":"Neurosci. Biobehav."},{"key":"BFnm1198_1308_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1523\/JNEUROSCI.13-03-00981.1993","volume":"13","author":"J Urenjak","year":"1993","unstructured":"Urenjak, J., Williams, S.R., Gadian, D.G. & Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981\u2013 989 (1993).","journal-title":"J. Neurosci."},{"key":"BFnm1198_1308_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ima.1850010210","volume":"1","author":"GL Brownell","year":"1989","unstructured":"Brownell, G.L.  et al. Development in high-resolution positron emission tomography at MGH. Int. J. Imag. Sys. Technol. 1, 207 \u201317 (1989).","journal-title":"Int. J. Imag. Sys. Technol."},{"key":"BFnm1198_1308_CR35","doi-asserted-by":"crossref","unstructured":"Derenzo, S.E., Huesman, R.H. & Cahoon, J.L. A positron tomograph with 600 BGO crystals and 2.6 mm resolution. IEEE Trans. Nucl. Sci. NS-35, 659\u2013664 (1988).","DOI":"10.1109\/23.12807"},{"key":"BFnm1198_1308_CR36","first-page":"13","volume-title":"The Metabolism of the Human Brain Studied With Positron Emission Tomography","author":"GL Brownell","year":"1985","unstructured":"Brownell, G.L., Burnham, C.A. & Chesler, D.A. in The Metabolism of the Human Brain Studied With Positron Emission Tomography, Ed. (eds. Greitz, T., Ingvar, D.H. & Widen, L.) 13\u201319 (Raven, New York, 1985)."},{"key":"BFnm1198_1308_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000115172","volume":"19","author":"O Bugiani","year":"1980","unstructured":"Bugiani, O., Perdelli, F., Salvarani, S., Leonardi, A. & Mancardi, G.L. Loss of striatal neurons in Parkinson's disease: a cytometric study. Eur. Neurol. 19, 339\u2013344 (1980).","journal-title":"Eur. Neurol."},{"key":"BFnm1198_1308_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/mrm.1910350502","volume":"35","author":"JH Hwang","year":"1996","unstructured":"Hwang, J.H.  et al. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in human brain.  Magn. Reson. Med. 35, 633\u2013639 (1996).","journal-title":"Magn. Reson. Med."},{"key":"BFnm1198_1308_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/jcbfm.1989.59","volume":"9","author":"JJ Frost","year":"1989","unstructured":"Frost, J.J.  et al. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.  J. Cereb. Blood Flow Metab. 9, 398\u2013 409 (1989).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnm1198_1308_CR40","doi-asserted-by":"crossref","unstructured":"Kaufman, M.J. & Madras, B.K. Severe depletion of cocaine recognition sites associated with the dopamine transporter in parkinson's diseased striatum. Synapse 9 (1991).","DOI":"10.1002\/syn.890090107"},{"key":"BFnm1198_1308_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0006-8993(88)90124-2","volume":"455","author":"TH McNeil","year":"1988","unstructured":"McNeil, T.H., Brown, S.A., Rafols, J.A. & Shoulson, I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res. 455, 148\u2013152 (1988).","journal-title":"Brain Res."},{"key":"BFnm1198_1308_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/mds.870120611","volume":"12","author":"F Federico","year":"1997","unstructured":"Federico, F.  et al. Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders. Mov. Disord. 12 , 903\u2013909 (1997).","journal-title":"Mov. Disord."},{"key":"BFnm1198_1308_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.870120306","volume":"12","author":"CE Clarke","year":"1997","unstructured":"Clarke, C.E., Lowry, M. & Horsman, A. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic parkinson's disease measured by protonmagnetic resonance spectroscopy. Mov. Disord. 12, 297\u2013301 (1997).","journal-title":"Mov. Disord."},{"key":"BFnm1198_1308_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0091-3057(93)90340-Y","volume":"46","author":"P Carvey","year":"1993","unstructured":"Carvey, P.  et al. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacol. Biochem. Behav. 46, 195\u2013204 (1993).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnm1198_1308_CR45","first-page":"1186","volume":"37","author":"A-L Brownell","year":"1996","unstructured":"Brownell, A.-L. et al. Cocaine congeners as PET imaging probes for dopamine terminals. J. Nucl. Med. 37, 1186\u2013 1192 (1996).","journal-title":"J. Nucl. Med."},{"key":"BFnm1198_1308_CR46","unstructured":"Chesler, D.A. Positron emission tomography and three-dimensional reconstruction technique. Tomograph. Imag. Nuc. Med. 176\u2013183 (1973)."},{"key":"BFnm1198_1308_CR47","first-page":"19","volume":"18","author":"DM Foster","year":"1994","unstructured":"Foster, D.M.  et al. SAAM II: simulation, analysis and modeling software.  BMES Bull 18, 19\u201321 ( 1994).","journal-title":"BMES Bull"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1198_1308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1198_1308","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1198_1308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:15:17Z","timestamp":1684448117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1198_1308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["BFnm1198_1308"],"URL":"https:\/\/doi.org\/10.1038\/3300","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}